Skip to main content
Pure Biologics S.A. logo

Pure Biologics S.A. — Investor Relations & Filings

Ticker · PUR ISIN · PLPRBLG00010 LEI · 2594002TXS19AUYHIF82 WAR Manufacturing
Open in API
Filings indexed 515 across all filing types
Latest filing 2024-09-30 Audit Report / Informat…
Country PL Poland
Listing WAR PUR

About Pure Biologics S.A.

https://purebiologics.com/

Pure Biologics S.A. is a biopharmaceutical company engaged in the discovery and development of novel biological drugs and non-systemic therapies. The company leverages its expertise in antibody and aptamer technologies to create innovative treatments. Its therapeutic portfolio is primarily focused on immuno-oncology. A key aspect of its strategy is the development of original, non-generic and non-biosimilar, biological drug candidates.

Recent filings

Filing Released Lang Actions
Raport biegłego rewidenta z przeglądu śródrocznego skróconego sprawozdania finansowego Pure Biologics S.A. za okres 01.01-30.06.2024
Audit Report / Information Classification · 99% confidence The document is explicitly titled "RAPORT NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z PRZEGLĄDU ŚRÓDROCZNEGO SKRÓCONEGO SPRAWOZDANIA FINANSOWEGO ZA OKRES 6 MIESIĘCY ZAKOŃCZONY DNIA 30 CZERWCA 2024 ROKU" (Independent Auditor's Report on the Review of the Interim Condensed Financial Statements for the 6-Month Period Ended June 30, 2024). This document contains the auditor's conclusion based on a review of interim financial statements (6 months). This aligns perfectly with the definition of an Audit Report / Information (AR), which covers standalone audit reports and results of internal/regulatory stress tests, distinct from the full Annual Report (10-K) or a general Interim Report (IR). The content details the scope of the review (Krajowy Standard Przeglądu 2410 / ISRE 2410) and provides a conclusion on the interim condensed financial statements. H1 2024
2024-09-30 Polish
Skrócone śródroczne sprawozdanie finansowe Pure Biologics S.A. za okres 01.01-30.06.2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Śródroczne skrócone sprawozdanie finansowe' (Interim Condensed Financial Statement) for the period ending 30.06.2024. It contains detailed financial statements (Income Statement, Balance Sheet, Cash Flow, Statement of Changes in Equity) and explanatory notes. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2024-09-30 Polish
Jednostkowy raport półroczny Pure Biologics S.A. za okres 01.01-30.06.2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Jednostkowy Raport Półroczny' (Standalone Semi-Annual Report) for the period ending 30.06.2024. It contains a comprehensive table of contents covering financial statements, auditor's reports, and management discussion and analysis (Sprawozdanie z działalności). As it is a full interim report containing substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2024
2024-09-30 Polish
Podpisanie umowy o dofinansowanie (umowa o fazowanie) projektu PB004 - Content (PL)
Capital/Financing Update Classification · 95% confidence The document is a 'Raport Bieżący' (Current Report) in Polish, referencing a signed agreement with the National Centre for Research and Development (NCBR) for project funding (dofinansowanie). It details the funding amount (4,415,625.00 PLN) and its purpose, which relates to continuing R&D for an anti-cancer drug (Project PB004). This announcement concerns financing activities and capital structure implications (reducing capital needs mentioned in a previous report). This fits best under 'Capital/Financing Update' (CAP) as it is a specific announcement about securing funds for ongoing operations/projects, rather than a general regulatory filing (RNS) or a management report (MDA). The document is short and specific, announcing a material financial event.
2024-09-26 Polish
Zawiadomienie zgodnie z art. 69 Ustawy o Ofercie_eCapital sp. z o.o.
Major Shareholding Notification Classification · 99% confidence The document is a formal notification in Polish, titled 'Zawiadomienie na podstawie art. 69 ust. 1 lub 2 ustawy o ofercie (wypełnia akcjonariusz)' which translates to 'Notification pursuant to Art. 69 sec. 1 or 2 of the Public Offering Act (to be completed by the shareholder)'. This type of filing specifically reports changes in significant share ownership thresholds by an existing shareholder. The content details the 'before' and 'after' shareholding percentages (5.03% changing to 4.96%) and the specific transaction (sale of 2,800 shares). This directly corresponds to the definition of Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2024-09-24 Polish
Zawiadomienie o zmianie stanu posiadania akcji Spółki - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (599 characters) and explicitly states that the company received a notification ('zawiadomienie') regarding a change in share ownership ('zmianie stanu posiadania akcji') from a shareholder (eCapital sp. z o.o.) based on Polish public offering law (Art. 69 of the Public Offering Act). It concludes by stating that the content of the notification is provided in the attachment to this current report ('niniejszym raportu bieżącego'). This structure—a brief announcement referencing an attached document detailing a change in significant shareholding—strongly suggests a notification of a change in major shareholding. The closest matching category is Major Shareholding Notification (MRQ). Although it mentions 'raport bieżący' (current report), the content itself is the notification of the change in ownership, not the general regulatory filing fallback (RNS) or a report publication announcement (RPA), as it contains the substance of the notification (the change in ownership threshold).
2024-09-24 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.